Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
35.26%
Operating Margin
17.91%
Net Margin
-216.52%

Efficiency Metrics

Revenue per Expense Ratio
1.22
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
-168.03%
Income Tax Rate
0.00%
EPS
-15.5000000000

Balance Sheet Analysis

Current Ratio
10.81
Cash Ratio
8.80
Working Capital
$466.89M
Debt to Equity
1.33
Debt to Assets
53.13%
Equity Ratio
39.86%

Cash Flow Analysis

Operating Cash Flow Ratio
35.06%
Free Cash Flow Ratio
35.06%
CapEx to Revenue
0.00%
Dividends Paid
$45.70M
Stock Buybacks
$129.44M
Total Shareholder Returns
$175.14M
Cash Position Change
68.53%

Key Takeaways (2023 FY)

  • Revenue declined by 38.945220115971%, indicating potential market challenges
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
-38.95%
Net Income
-37.07%
EPS
-39.14%
Operating Income
-43.92%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
-3.97%
Operating Cash Flow
-41.61%
Free Cash Flow
108.92%

Balance Sheet Health

Assets
-23.22%
Debt
-3.25%
Book Value per Share
-39.28%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
-63.13%
Shares Outstanding
-0.19%

Long Term Trends

3Y Revenue/Share
308.96%
5Y Revenue/Share
14.59%
3Y Dividend/Share
262.69%
5Y Dividend/Share
-70.01%